MedTrace Logo

An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma

NCT05217147 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-09-22

No results posted yet for this study

Summary

The aim of this study was to determine serum levels of VEGF, sVEGFR1, VEGFR2, IGFBP-3, angiogenin and endoglin in patients with larynx squamous cell carcinoma; investigate their association with clinical parameters and determine their diagnostic and prognostic value.

Conditions

  • Larynx Cancer
  • Larynx Carcinoma

Interventions

OTHER

Obtaining blood samples

Blood samples were obtained at time of diagnosis and will be analyzed for the levels of biomarker candidate molecules.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Gurcan Gunaydin, MD, PhD · Hacettepe University Cancer Institute

  • Nilda Suslu · Hacettepe University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2020-02-01
Completion
2021-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05217147 on ClinicalTrials.gov